Extendicare Inc. (TSE:EXE – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$18.31 and traded as high as C$24.88. Extendicare shares last traded at C$24.55, with a volume of 1,167,487 shares trading hands.
Analyst Upgrades and Downgrades
Several research analysts recently commented on the company. TD Securities raised their price target on Extendicare from C$15.00 to C$19.00 in a research report on Thursday, November 13th. Cormark lifted their price target on shares of Extendicare from C$25.00 to C$30.00 in a research note on Wednesday, December 3rd. BMO Capital Markets upgraded shares of Extendicare from a “hold” rating to an “outperform” rating and upped their price target for the company from C$21.00 to C$24.00 in a report on Thursday, December 4th. Royal Bank Of Canada raised shares of Extendicare from a “hold” rating to a “moderate buy” rating and raised their price objective for the stock from C$15.00 to C$25.00 in a research note on Thursday, December 4th. Finally, Canadian Imperial Bank of Commerce boosted their target price on Extendicare from C$18.00 to C$22.00 in a research report on Thursday, November 13th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, Extendicare currently has a consensus rating of “Buy” and an average target price of C$24.50.
Extendicare Stock Performance
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Articles
- Five stocks we like better than Extendicare
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
